| 前收市價 | 0.2500 |
| 開市 | 0.2000 |
| 買盤 | 0.1000 |
| 賣出價 | 0.3000 |
| 拍板 | 55.00 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 0.2000 - 0.2000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 5.01k |
ZacksShould You Buy Legend Biotech (LEGN) Ahead of Earnings?
Legend Biotech (LEGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ZacksFDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
Following the label expansion, J&J's (JNJ) Carvykti is approved as a second-line treatment for adults with relapsed/refractory myeloma. It was initially approved for use as a fifth- or later-line treatment.
- Zacks
Why Legend Biotech (LEGN) Stock Might be a Great Pick
Legend Biotech (LEGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
